The world-class Gene Therapy CDMO Partner From Concept to Commercialization
Since 2015, uBriGene Biosciences International Co. has been dedicated to shaping the future of biotechnology by advancing life-changing therapies and technology platforms for its clients worldwide. With a fully-integrated offering, uBriGene supports global capacity, technical expertise and the scientific depth required to assist drug development companies throughout their journey – from early research application and proof-of- concept, through clinical and late-phase regulatory domain.
uBriGene has an established global footprint with two GMP manufacturing facilities in China and Regional Headquarters in Richmond, BC Canada. The newly acquired state-of-the-art facility in greater Boston area, has the GMP manufacturing capacity to serve the cell and gene therapies, as well as providing contract analytical services.